We are delighted to share that the MULTIR Project was showcased at the 2024 European Cancer Summit, held on 20-21 November. The European Cancer Organisation extended an invitation for MULTIR to be featured in a dedicated section highlighting EU-funded cancer initiatives, emphasizing its role in advancing Europe’s Beating Cancer Plan and the EU Cancer Mission.
The European Cancer Summit is a key annual event that brings together oncology experts, patient advocates, policymakers, and politicians from across Europe to drive forward efforts against cancer. This year’s Summit saw record-breaking registrations and featured numerous groundbreaking cancer projects supported by the EU.
As part of this opportunity, the MULTIR team submitted a dedicated slide presentation (16:9 format), which was displayed alongside other EU-funded cancer initiatives. This presentation provided an overview of the project’s objectives, key contributions, and the team’s ongoing efforts in the fight against cancer.
We are proud to have been part of this prestigious event and to have shared MULTIR’s impact with a broad audience of stakeholders and decision-makers. This recognition reinforces our commitment to collaborative cancer research and innovation.
For more information about the European Cancer Summit 2024, please visit https://www.europeancancer.org/summit.html.
Thank you to the MULTIR team for their contributions and ongoing dedication!
Comments